Literature DB >> 9536027

Tumor necrosis factor-alpha as a contributor in fumonisin B1 toxicity.

R R Dugyala1, R P Sharma, M Tsunoda, R T Riley.   

Abstract

Fumonisin B1 is a toxic product of Fusarium moniliforme, which inhibits ceramide synthase, leading to accumulation of free sphingoid bases. Despite its known biochemical action, the mechanism of toxicity is not fully understood. Male BALB/c mice were injected subcutaneously with 0 to 6.75 mg/kg/day of fumonisin B1 for 5 days. One day after the last treatment, spleens were collected, and peritoneal macrophages were obtained from separate groups after an intraperitoneal injection of thioglycolate broth. Peripheral leukocyte counts were increased and kidney weights were decreased by fumonisin B1 treatment. Presence of apoptotic cells in the liver and kidney of treated mice was confirmed by enzymatic immunoassay. Macrophages cultured with lipopolysaccharide indicated an increased secretion of tumor necrosis factor-alpha (TNF-alpha) but not of interleukin-1alpha. No effect was seen on interferon-gamma production when splenocytes were incubated with concanavalin A. Elevation of leukocyte and reticulocyte counts was abrogated by pretreatment with anti-TNF-alpha antibody before a single dose of fumonisin B1 (25 mg/kg), supporting the hypothesis that the fumonisin B1 toxicity involves TNF-alpha. Cultures of J774A.1 cells, when treated with fumonisin B1, produced TNF-alpha in vitro. Results indicate that fumonisin B1 toxicity may involve secretion of TNF-alpha by TNF-alpha-producing cells without altering interleukin-1alpha or interferon-gamma. The influence on TNF-alpha-production may be a contributing factor to fumonisin B1-induced apoptosis and other observed toxic effects in animals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9536027

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Protection of a ceramide synthase 2 null mouse from drug-induced liver injury: role of gap junction dysfunction and connexin 32 mislocalization.

Authors:  Woo-Jae Park; Joo-Won Park; Racheli Erez-Roman; Aviram Kogot-Levin; Jessica R Bame; Boaz Tirosh; Ann Saada; Alfred H Merrill; Yael Pewzner-Jung; Anthony H Futerman
Journal:  J Biol Chem       Date:  2013-09-09       Impact factor: 5.157

Review 2.  The role of dihydrosphingolipids in disease.

Authors:  Ruth R Magaye; Feby Savira; Yue Hua; Darren J Kelly; Christopher Reid; Bernard Flynn; Danny Liew; Bing H Wang
Journal:  Cell Mol Life Sci       Date:  2018-12-06       Impact factor: 9.261

3.  Inducible nitric oxide has protective effect on fumonisin B1 hepatotoxicity in mice via modulation of sphingosine kinase.

Authors:  Hirofumi Suzuki; Ronald T Riley; Raghubir P Sharma
Journal:  Toxicology       Date:  2006-09-29       Impact factor: 4.221

4.  Analysis of fumonisin B1-induced apoptosis.

Authors:  C Jones; J R Ciacci-Zanella; Y Zhang; G Henderson; M Dickman
Journal:  Environ Health Perspect       Date:  2001-05       Impact factor: 9.031

Review 5.  Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.

Authors:  R T Riley; E Enongene; K A Voss; W P Norred; F I Meredith; R P Sharma; J Spitsbergen; D E Williams; D B Carlson; A H Merrill
Journal:  Environ Health Perspect       Date:  2001-05       Impact factor: 9.031

Review 6.  Dietary and Endogenous Sphingolipid Metabolism in Chronic Inflammation.

Authors:  Gregory H Norris; Christopher N Blesso
Journal:  Nutrients       Date:  2017-10-28       Impact factor: 5.717

7.  Protective effects of silymarin on fumonisin B₁-induced hepatotoxicity in mice.

Authors:  Mahmut Sozmen; Alparslan Kadir Devrim; Recai Tunca; Murat Bayezit; Serpil Dag; Dinc Essiz
Journal:  J Vet Sci       Date:  2013-10-18       Impact factor: 1.672

Review 8.  Research Progress on Fumonisin B1 Contamination and Toxicity: A Review.

Authors:  Jia Chen; Jun Wen; Yating Tang; Jichao Shi; Guodong Mu; Rong Yan; Jing Cai; Miao Long
Journal:  Molecules       Date:  2021-08-29       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.